Dehydroepiandrosterone sulphate serum levels in systemic sclerosis

Clinical and Experimental Rheumatology

Volumn 19, Issue 1, 2001, Pages 21-26

  La Montagna, G ^a   Baruffo, A ^a   Buono, G ^a   Valentini, G ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Dehydroepiandrosterone sulphate; Systemic sclerosis

Indexed keywords

CISAPRIDE; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GRISEOFULVIN; HYDROXYCHLOROQUINE; INTERLEUKIN 2 RECEPTOR; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PENICILLAMINE; PENTOXIFYLLINE; PRASTERONE SULFATE; PREDNISONE; RANITIDINE; STEROID;

ADULT; AGE; ANDROGEN BLOOD LEVEL; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; DISEASE SEVERITY; DRUG USE; EVALUATION; FEMALE; HORMONAL REGULATION; HUMAN; MEASUREMENT; POSTMENOPAUSE; PREGNANCY; PREMENOPAUSE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REPRODUCTION; SCORING SYSTEM; STATISTICS; STEROID THERAPY; SYSTEMIC SCLEROSIS;

ADOLESCENT; ADULT; AGED; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; HUMANS; MIDDLE AGED; REGRESSION ANALYSIS; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; WOMEN'S HEALTH;

EID: 0035096409     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Scleroderma
2. High prolactin and low dehydroepiandrosterone sulphate serum levels in patients with severe systemic sclerosis
3. Blood dehydroepiandrosterone sulphate (DHEAS) levels in pemphigoid/pemphigus and psoriasis
4. Blood and tissue dehydroepiandrosterone sulphate levels and their relationship to chronic inflammatory bowel disease
5. Blood dehydroepiandrosterone sulphate (DHEAS) levels in polymyalgia rheumatica/giant cell arteritis and primary fibromyalgia
6. Relationship between blood and joint tissue DHEAS levels in rheumatoid arthritis and osteoarthritis
7. Low plasma androgens in women with systemic lupus erythematosus (SLE)
8. Low sulphoconjugated steroid hormone levels in systemic lupus erythematosus
9. Dehydroepiandrosterone (DHEA) and systemic lupus erythematosus
10. Blood cortisol and dehydroepiandrosterone sulphate (DHEAS) levels in CD4 T cell counts in HIV infection
11. Preliminary criteria for classification of systemic sclerosis (scleroderma)
12. Different antibody patterns and different prognoses in patients with scleroderma with various extents of skin sclerosis
13. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis
14. A disease severity scale for systemic sclerosis: Development and testing
15. Skin thickness and collagen content in progressive systemic sclerosis and localised scleroderma
16. Changes in androgens during treatment with four low-dose contraceptives
17. The calcium channel blocker amlodipine raises serum dehydroepiandrosterone sulphate and androstenedione, but lowers serum cortisol, in insulin-resistant obese and hypertensive men
18. The relation of smoking, age, relative weight, and dietary intake to serum adrenal steroids, sex hormones, and sex hormone-binding globulin in middle aged men
19. Reduced plasma dehydroepiandrosterone concentrations in Alzheimer's disease
20. Dehydroepiandrosterone (DHEA): The multifunctional steroid II. Effect on the CNS cell proliferation, metabolic and vascular, clinical and other effects. Mechanism of action?
21. DHEA and immune function: Activities and mechanism of action
22. An open study of dehydroepiandrosterone in systemic lupus erythematosus
23. Decreased serum dehydroepiandrosterone sulfate (DHEAS) levels before onset of RA in younger, pre-menopausal women: A controlled, prospective study
24. Hormonal and pregnancy relationships to rheumatoid arthritis: Convergent effects with immunologic and microvascular systems
25. The adrenal response to oCRH and low dose ACTH in pre-menopausal rheumatoid arthritis patients
26. Integrated hormonal-immunological-vascular (H-I-Y triad) systems interactions in the rheumatic diseases
27. Perturbations of the hypothalamic pituitary gonadal axis in rheumatoid arthritis
28. The cellular and subcellular bases of immunosenescence
29. The presence of a dehydroepiandrosterone-specific receptor binding complex in murine T cells
30. Hormones and lupus: Defective DHEA activity induces impaired intereleukin-2 activity of T lymphocytes in patients with systemic lupus erythematosus
31. Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor
32. Inhibition of NFkB activity through maintenence of IkBa levels contributes to dehydroepiandrosterone-mediated repression of IL-6 promoter
33. Immunopathogenesis of systemic sclerosis
34. Pathogenesis of scleroderma: Collagen
35. Androgen replacement therapy in male patients with rheumatoid arthritis
36. The role of the hypothalamus-pituitary-adrenocortical and gonadal axis in rheumatoid arthritis
37. Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months